IUHSA
BIIB icon

Itau Unibanco Holding S.A.’s Biogen BIIB Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-70
Closed -$1K – 341
2019
Q2 		$1K Buy
+70
New +$16.2K ﹤0.01% 630

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Itau Unibanco Holding S.A.'s BIIB Position: Q1 2026 in Review

Itau Unibanco Holding S.A. increased its Biogen (BIIB) stake by 3.6% in Q1 2026, buying an estimated $2.21K and bringing the position to 349 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #227.

Itau Unibanco Holding S.A. first reported a position in BIIB in Q3 2016 and has held it in 33 quarters since. The position peaked at $2.78M in Q3 2017. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Itau Unibanco Holding S.A. held 349 shares of Biogen worth $64K as of Q1 2026.
  • Itau Unibanco Holding S.A. bought 12 Biogen shares in Q1 2026, an estimated $2.21K.
  • Biogen made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q1 2026, its #227 holding.
  • Itau Unibanco Holding S.A. first reported a position in Biogen in Q3 2016 and has held it in 33 quarters since.
  • Itau Unibanco Holding S.A.'s Biogen position peaked at $2.78M in Q3 2017.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2026, filed 14 May 2026.